This presumption can have damaging effects for patients with neurological symptoms, which can become irreversible with insufficient treatment
Other clinical findings include respiratory depression, nausea, vomiting, diarrhoea, hypothermia or fever, hypotension, tachycardia, miosis, agitation, hallucinations, tremors, myoclonus and seizures
Secher A, Jelsing J, Baquero AF, Hecksher-Srensen J, Cowley MA, Dalbge LS, Hansen G, Grove KL, Pyke C, Raun K, et al
1.1 Expanded indications and increasing disease prevalence In addition to type 2 diabetes and weight management as key battlegrounds today, GLP-1 therapies have shown clinical promise in treating a wider array of conditions, including Alzheimers disease, cardiovascular risk reduction , MASH (metabolic dysfunction-associated steatohepatitis) and chronic kidney disease (CKD)